Gentex (GNTX) Cash & Equivalents (2009 - 2026)

Gentex has reported Cash & Equivalents for 18 years, with the latest figure at $164.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 42.5% year-over-year to $164.8 million; the trailing twelve-month figure through Mar 2026 stood at $164.8 million (down 42.5% YoY), and the FY2025 full-year result was $145.6 million, down 37.58% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $164.8 million, up from $145.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $286.6 million in Q1 2025, with the low at $119.8 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $220.3 million across 5 years, with a median of $226.4 million in 2023.
• Annual changes were most pronounced in 2023 — Cash & Equivalents gained 16.91% — and 2025, when it sank 53.98%.
• Gentex's Cash & Equivalents stood at $214.8 million in 2022, then climbed by 5.44% to $226.4 million in 2023, then advanced by 3.04% to $233.3 million in 2024, then slumped by 37.58% to $145.6 million in 2025, then grew by 13.12% to $164.8 million in 2026.
• The last three Cash & Equivalents figures came in at $164.8 million (Q1 2026), $145.6 million (Q4 2025), and $178.6 million (Q3 2025), per Business Quant data.